Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BKV Corporation enters the final stretch before its November 6 earnings report with short interest close to doubling over the past month, even as the analyst consensus points to more than 50% upside from current levels.
The short-side story is the most striking feature of the current setup. Short interest has risen 88% over the past 30 days, reaching 11.5% of the free float as of October 6. The one-week change of 10.3% shows the build has not slowed, even after a slight pullback on Tuesday. For context, short interest was running near 5% of float in early September; it has now doubled in a matter of weeks. The ORTEX short score at 70.4, broadly stable in the 69-to-73 range over the past ten days, reflects that the positioning is elevated but not yet at an extreme. Borrowing costs, at 0.64%, have risen 21% over the week but remain cheap in absolute terms. Availability is 228%, meaning there are more than two shares available to lend for every share already borrowed, so the borrow market is not tight and there is no mechanical squeeze pressure.
Options positioning adds a layer of nuance. The put/call ratio has climbed to 0.20, near its 52-week high of 0.22 and well above the August reading of 0.04, which represents the heaviest relative demand for downside protection BKV options have seen all year. The z-score of 0.84 against the 20-day mean keeps it below an alarm level, but the direction of travel since early September is clear. Taken together, the picture is of a market leaning skeptical: shorts rebuilding aggressively, puts moving toward their annual ceiling, yet borrow conditions remaining loose enough that the short interest could grow further without mechanical friction.
The Street has barely moved in the past three weeks, and the analyst community's conviction remains firmly bullish. Evercore ISI trimmed its target to $32 on September 18, while Barclays edged its target up to $36 the day before. Most other coverage has been holding positive ratings (Buy, Outperform, Overweight) despite a pattern of small target cuts through the summer. The mean target is $34 against a closing price of $22.05, a gap of roughly 54%. Bulls lean on BKV's gas production growth, the Temple power complex's expected EBITDA generation under Texas Senate Bill 6, and the longer-term optionality of its carbon capture unit. Bears flag the slow earnings ramp in the CCUS segment, exposure to natural gas prices, and the risk that data-center demand for power, a key plank of the bull case, could disappoint. The EV/EBITDA of 5.4x is undemanding for the sector. The 30-day change in the PE ratio, down about 2.8 turns to 11.8x, reflects the stock's 15% slide over the past month. The EPS surprise factor rank of 89 tells you the company has a strong recent history of beating estimates, even as the 12-month forward earnings growth rank of 19 shows the Street is not pricing in strong near-term upgrades.
One ownership feature worth noting is the activist dimension. Banpu Public Company Limited, BKV's Thai parent and controlling shareholder, holds approximately 63% of shares and has a Schedule 13D on file. As a reminder, 13D/G positions are event-driven disclosures and stakes are as last disclosed around the 5% threshold. On the institutional side, Greenlight Capital added about 400,000 shares in the June quarter, and BlackRock built its position by 633,000 shares through September. The insider register is less encouraging in the near term: the CFO and several other executives have been selling under pre-arranged 10b5-1 plans, with net insider selling of roughly $900,000 over the past 90 days. These are planned disposals, not discretionary, which limits the signal, but the direction is worth registering.
After the last earnings print in August, BKV gained 6.3% on the day and 12.7% over the following five days, a notable post-results bounce. The November 6 report arrives with the stock sitting 15% below its one-month-ago level and a short book that has nearly doubled in size. What to watch next is whether the short build continues into the earnings window or begins to unwind as the stock stabilises near multi-month lows, and whether the peer group's stronger week (close correlates GPOR, EQT and AR each gained 6% to 8% this week against BKV's 1.9%) begins to pull BKV back toward the group.
See the live data behind this article on ORTEX.
Open BKV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
